Litcius/Paper detail

Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells

Daniel Baker, Bruce L. Levine, Carl H. June

2025The Lancet13 citationsDOI

Topics & Concepts

Chimeric antigen receptorTerm (time)AntigenImmunologyMedicineVirologyCancer researchImmunotherapyImmune systemQuantum mechanicsPhysicsCAR-T cell therapy researchVirus-based gene therapy researchBiomedical Ethics and Regulation
Assessing the oncogenic risk: the long-term safety of autologous chimeric antigen receptor T cells | Litcius